4.6 Article

Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Therapeutic strategies for inhibiting invasion in glioblastoma

Jan Drappatz et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)

Article Biochemistry & Molecular Biology

Bcl-2 siRNA Augments Taxol Mediated Apoptotic Death in Human Glioblastoma U138MG and U251MG Cells

Joseph George et al.

NEUROCHEMICAL RESEARCH (2009)

Review Oncology

Cancer cells survive with survivin

Hirofumi Yamamoto et al.

CANCER SCIENCE (2008)

Review Pharmacology & Pharmacy

Targeting survivin in cancer therapy

Marzia Pennati et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2008)

Article Oncology

Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin

Anthony W. Tolcher et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Review Biochemistry & Molecular Biology

New wirings in the survivin networks

D. C. Altieri

ONCOGENE (2008)

Review Oncology

Structural, functional and therapeutic biology of survivin

N. K. Sah et al.

CANCER LETTERS (2006)

Article Cell Biology

The case for survivin as a regulator of microtubule dynamics and cell-death decisions

Dario C. Altieri

CURRENT OPINION IN CELL BIOLOGY (2006)

Article Oncology

Anticancer effects of fenretinide in human medulloblastoma

CD Reddy et al.

CANCER LETTERS (2006)

Review Oncology

Validating survivin as a cancer therapeutic target

DC Altieri

NATURE REVIEWS CANCER (2003)

Article Oncology

Quantitatively determined survivin expression levels are of prognostic value in human gliomas

A Chakravarti et al.

JOURNAL OF CLINICAL ONCOLOGY (2002)

Article Biochemistry & Molecular Biology

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53

WH Hoffman et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Review Biochemistry & Molecular Biology

The hallmarks of cancer

D Hanahan et al.